Success Metrics

Clinical Success Rate
84.6%

Based on 11 completed trials

Completion Rate
85%(11/13)
Active Trials
0(0%)
Results Posted
45%(5 trials)
Terminated
2(14%)

Phase Distribution

Ph phase_2
1
7%
Ph not_applicable
13
93%

Phase Distribution

0

Early Stage

1

Mid Stage

0

Late Stage

Phase Distribution14 total trials
Phase 2Efficacy & side effects
1(7.1%)
N/ANon-phased studies
13(92.9%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

84.6%

11 of 13 finished

Non-Completion Rate

15.4%

2 ended early

Currently Active

0

trials recruiting

Total Trials

14

all time

Status Distribution
Active(1)
Completed(11)
Terminated(2)

Detailed Status

Completed11
Terminated2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
14
Active
0
Success Rate
84.6%
Most Advanced
Phase 2

Trials by Phase

Phase 21 (7.1%)
N/A13 (92.9%)

Trials by Status

terminated214%
not_yet_recruiting17%
completed1179%

Recent Activity

Clinical Trials (14)

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
14